Myasthenia gravis: Association of British Neurologists' management guidelines

J Sussman, ME Farrugia, P Maddison, M Hill… - Practical …, 2015 - pn.bmj.com
Myasthenia gravis is an autoimmune disease of the neuromuscular junction for which many
therapies were developed before the era of evidence based medicine. The basic principles …

Glial lineages and myelination in the central nervous system

A COMPSTON, J ZAJICEK, JON Sussman… - The Journal of …, 1997 - cambridge.org
Oligodendrocytes, derived from stem cell precursors which arise in subventricular zones of
the developing central nervous system, have as their specialist role the synthesis and …

Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08

PK Gregersen, R Kosoy, AT Lee, J Lamb… - Annals of …, 2012 - Wiley Online Library
Objective: The objective of this study is to comprehensively define the genetic basis of early
onset myasthenia gravis (EOMG). Methods: We have carried out a 2‐stage genome‐wide …

[HTML][HTML] Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA …

MF Seldin, OK Alkhairy, AT Lee, JA Lamb… - Molecular …, 2015 - Springer
To investigate the genetics of late-onset myasthenia gravis (LOMG), we conducted a
genome-wide association study imputation of> 6 million single nucleotide polymorphisms …

Musician's dystonia

J Sussman - Practical Neurology, 2015 - pn.bmj.com
Musician's dystonia is a task-specific dystonia that usually affects the embouchure or the
most active digits of the most active hand, and therefore differs between instruments. Since it …

Transgender health care curriculum development: a dual-site medical school campus pilot

AJ Najor, JM Kling, RL Imhof, JD Sussman… - Health …, 2020 - liebertpub.com
Purpose: Lack of physician training contributes to health care disparities for transgender
people. The limited generalizability and feasibility of published training approaches lessen …

Minimal manifestation status and prednisone withdrawal in the MGTX trial

I Lee, HC Kuo, IB Aban, GR Cutter, T McPherson… - Neurology, 2020 - AAN Enterprises
Objective To examine whether sustained minimal manifestation status (MMS) with complete
withdrawal of prednisone is better achieved in thymectomized patients with myasthenia …

The Association of British Neurologists' myasthenia gravis guidelines

J Sussman, ME Farrugia, P Maddison… - Annals of the New …, 2018 - Wiley Online Library
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction for which
many therapies were developed before the era of evidence‐based medicine. Despite the …

Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note

JM Graham, JD Sussman, KS Ford… - Journal of Neurology …, 1998 - jnnp.bmj.com
BACKGROUND Hallucinosis is a dopaminergic dose limiting complication of the treatment
of idiopathic Parkinson's disease. Typical neuroleptic medications cannot be used for …

Antisense treatment for myasthenia gravis: experience with monarsen

JD Sussman, Z Argov, D McKee… - Annals of the New …, 2008 - Wiley Online Library
Acetylcholinesterase pre‐mRNA is susceptible to alternative splicing. Myasthenia gravis has
been shown to be associated with the expression of the readthrough transcript (AChE‐R) …